Repligen Corp. | Cash Flow

Fiscal year is January-December. All values USD Thousands.
2013
2014
2015
2016
2017
2018
Net Income before Extraordinaries
16,093.20
8,170.20
9,345.00
11,681.00
28,353.00
16,617
Depreciation, Depletion & Amortization
3,113.90
4,019.40
4,594.00
5,334.00
10,507.00
15,778
Other Funds
72.00
-
99.00
798.00
1,715.00
14,437
Funds from Operations
24,349.50
16,358.30
21,503.00
23,026.00
24,969.00
46,903
Changes in Working Capital
1,580.50
2,043.00
6,450.00
15,505.00
7,518.00
14,133
Net Operating Cash Flow
25,930.00
18,401.30
15,053.00
7,521.00
17,451.00
32,770
Capital Expenditures
4,634.80
5,602.50
2,628.00
4,325.00
5,454.00
Sale of Fixed Assets & Businesses
-
-
-
45.00
-
Purchase/Sale of Investments
13,271.50
7,296.30
7,419.00
300.00
20,003.00
Net Investing Cash Flow
17,906.30
19,792.20
4,791.00
49,194.00
98,246.00
Issuance/Reduction of Debt, Net
-
-
-
111,070.00
-
Net Financing Cash Flow
2,522.20
1,680.40
767.00
112,113.00
129,945.00
Net Change in Cash
10,619.80
4,466.60
18,729.00
68,141.00
51,526.00
Free Cash Flow
21,295.20
12,798.80
12,425.00
3,196.00
11,997.00
Deferred Taxes & Investment Tax Credit
2,788.00
295.10
118.00
4,092.00
24,679.00
71
Net Assets from Acquisitions
-
21,235.90
-
44,614.00
112,795.00
Change in Capital Stock
2,450.20
1,680.40
866.00
1,841.00
131,660.00
Exchange Rate Effect
74.00
4,756.10
1,882.00
2,299.00
2,376.00
Other Uses
-
250.00
-
-
-

About Repligen

View Profile
Address
41 Seyon Street
Waltham Massachusetts 02453
United States
Employees -
Website http://www.repligen.com
Updated 07/08/2019
Repligen Corp. engages in the provision of bioprocessing technology and solutions. It operates through the following geographical segments: United States; Sweden; United Kingdom; and Other. It also serve through the following product lines: Protein; Filtration; Chromatography; and Other.